Pearl DCB
(Drug Coated Coronary Balloon Catheter)

Features:

• Drug & excipient placed within the Tri-fold of the balloon to ensure minimum drug loss during transition.
• Used UREA as an excipient, which forms a crystalline structure with paclitaxel.
• Crystalline matrix allows stable & firm drug coating during storage and handling at the same time enables quick dissolution & rapid release of Paclitaxel at the vessel wall upon inflation.
• Paclitaxel is loaded at a dose of 3 micrograms/mm² & ensures effective drug concentration (1.98ng/mg) in the vascular wall for more than 28 days to inhibit restenosis.

Product specification